Liqin Zhou

552 total citations · 1 hit paper
16 papers, 401 citations indexed

About

Liqin Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Liqin Zhou has authored 16 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Pharmacology. Recurrent topics in Liqin Zhou's work include Fibroblast Growth Factor Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Plant-derived Lignans Synthesis and Bioactivity (3 papers). Liqin Zhou is often cited by papers focused on Fibroblast Growth Factor Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Plant-derived Lignans Synthesis and Bioactivity (3 papers). Liqin Zhou collaborates with scholars based in China, Germany and Australia. Liqin Zhou's co-authors include Dayong Lou, Qinjie Weng, Jincheng Wang, Jiajia Wang, Bo Yang, Chunyan Fang, Qiaojun He, Min Li, Youguo Chen and Liqin Jiang and has published in prestigious journals such as Cell Death and Differentiation, Frontiers in Pharmacology and Phytomedicine.

In The Last Decade

Liqin Zhou

15 papers receiving 393 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural products: potential treatments for cisplatin-induced nephrotoxicity

2021 258 citations Chunyan Fang, Dayong Lou et al. Acta Pharmacologica Sinica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liqin Zhou China	8	161	146	61	54	44	16	401
Baiye Jin China	11	198 1.2×	153 1.0×	42 0.7×	36 0.7×	63 1.4×	34	515
Asmaa M. A. Bayoumi Egypt	13	89 0.6×	112 0.8×	27 0.4×	60 1.1×	33 0.8×	26	408
Cierra N. Sharp United States	10	227 1.4×	160 1.1×	22 0.4×	115 2.1×	33 0.8×	17	423
Dayong Lou China	5	166 1.0×	78 0.5×	14 0.2×	53 1.0×	35 0.8×	13	318
Seham A. Abdel-Gaber Egypt	15	109 0.7×	141 1.0×	24 0.4×	11 0.2×	51 1.2×	29	461
Zhengtao Liu China	13	81 0.5×	140 1.0×	34 0.6×	66 1.2×	43 1.0×	31	639
Ademar Dantas da Cunha Júnior Brazil	7	190 1.2×	60 0.4×	14 0.2×	78 1.4×	59 1.3×	8	331
Blessy George United States	9	90 0.6×	73 0.5×	13 0.2×	81 1.5×	56 1.3×	20	353
Yin Li China	15	87 0.5×	245 1.7×	81 1.3×	115 2.1×	78 1.8×	27	611
Mohammad A. BaSalamah Saudi Arabia	13	86 0.5×	130 0.9×	48 0.8×	8 0.1×	62 1.4×	22	486

Countries citing papers authored by Liqin Zhou

Since Specialization

Citations

This map shows the geographic impact of Liqin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqin Zhou more than expected).

Fields of papers citing papers by Liqin Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqin Zhou. The network helps show where Liqin Zhou may publish in the future.

Co-authorship network of co-authors of Liqin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Liqin Zhou. A scholar is included among the top collaborators of Liqin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqin Zhou. Liqin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ma, Qing, Shuo Huang, Fang‐Ming Chen, et al.. (2025). Dihydromyricetin regulates the miR-155-5p/SIRT1/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury. Phytomedicine. 139. 156522–156522. 4 indexed citations

Wang, Xinye, Xinyu Wu, Liqin Zhou, et al.. (2025). Demethyleneberberine ameliorates pulmonary fibrosis by inhibiting the NLRP3 inflammasome and the epithelial–mesenchymal transition. International Immunopharmacology. 161. 115003–115003.

Lou, Dayong, et al.. (2024). Dihydromyricetin reverses capecitabine‐induced peripheral myelin dysfunction through modulation of oxidative stress. Clinical and Experimental Pharmacology and Physiology. 51(3). e13833–e13833. 1 indexed citations

Zhou, Liqin, et al.. (2024). Evidence that a Novel Chalcone Derivative, Compound 27, Acts on the Epithelium Via the PI3K/AKT/Nrf2-Keap1 Signaling Pathway, to Mitigate LPS-Induced Acute Lung Injury in Mice. Inflammation. 48(2). 590–606. 1 indexed citations

Zhou, Liqin, et al.. (2024). Correction: Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy. Revista Brasileira de Farmacognosia. 34(4). 880–881. 1 indexed citations

Zhou, Liqin, et al.. (2023). Schisandrin B Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis Through PI3K/AKT/mTOR Pathway Mediated Autophagy. Revista Brasileira de Farmacognosia. 33(5). 945–953. 2 indexed citations

Liu, Li, Kankai Wang, Qian Yao, et al.. (2022). Fibroblast growth factor 10 protects against particulate matter-induced lung injury by inhibiting oxidative stress-mediated pyroptosis via the PI3K/Akt/Nrf2 signaling pathway. International Immunopharmacology. 113(Pt A). 109398–109398. 17 indexed citations

Kong, Xiaoxia, et al.. (2022). FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway. Frontiers in Pharmacology. 13. 1019755–1019755. 7 indexed citations

Cai, Yajun, et al.. (2022). Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells. Journal of Gastrointestinal Oncology. 13(3). 1255–1265. 3 indexed citations

10.

Gui, Tao, Ming Liu, Bing Yao, et al.. (2021). TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer. Cell Death and Differentiation. 28(12). 3316–3328. 33 indexed citations

11.

Fang, Chunyan, Dayong Lou, Liqin Zhou, et al.. (2021). Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacologica Sinica. 42(12). 1951–1969. 258 indexed citations breakdown →

12.

Li, Min, et al.. (2020). Circular PVT1 regulates cell proliferation and invasion via miR-149-5p/FOXM1 axis in ovarian cancer. Journal of Cancer. 12(2). 611–621. 29 indexed citations

13.

Han, Jibo, Liqin Zhou, Qi Yu, et al.. (2018). Inhibition of Epidermal Growth Factor Receptor (EGFR) Reduces Lipopolysaccharide (LPS)-Induced Activation and Inflammatory Cytokines in Hepatic Stellate Cells In Vitro. Medical Science Monitor. 24. 5533–5541. 12 indexed citations

14.

Lou, Dayong, et al.. (2018). Fibroblast growth factor receptor 1 antagonism attenuates lipopolysaccharide‑induced activation of hepatic stellate cells via suppressing inflammation. Experimental and Therapeutic Medicine. 16(4). 2909–2916. 14 indexed citations

15.

Han, Jibo, Liqin Jiang, Jianjiang Xu, et al.. (2018). Schisandrin B attenuates lipopolysaccharide-induced activation of hepatic stellate cells through Nrf-2-activating anti-oxidative activity.. PubMed. 11(10). 4917–4925. 3 indexed citations

16.

Qi, Xiulan, et al.. (2012). Toll-like receptor 4 signaling promotes the immunosuppressive cytokine production of human cervical cancer.. PubMed. 33(3). 291–4. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact